Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alzheimer Disease
Leuprolide acetate therapy is under study
May 12th, 2005
Leuprolide acetate, which suppresses luteinizing hormone secretion, is being studied for therapeutic use in Alzheimer disease. Research results suggest luteinizing hormone may be involved in AD pathogenesis. "Differences in the prevalence and age of onset of Alzheimer disease (AD) in men and women, and observations that hormone replacement therapy (HRT) may prevent the development of AD, caused many to hypothesize that estrogen deficiency contributes to AD. However, recent trials using estrogen failed to show any benefit in preventing or alleviating the disease," said G. Casadesus and colleagues, Case Western Reserve University, Cleveland. ...
Source: Women's Health Weekly (2005-05-12)
|
